The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States

Hepatology

Volumn 31, Issue 3, 2000, Pages 777-782

  Armstrong, Gregory L ^a,b,d   Alter, Miriam J ^b   McQuillan, Geraldine M ^c   Margolis, Harold S ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC LIVER DISEASE; HEALTH SURVEY; HEPATITIS C; HUMAN; INFECTION RISK; PRIORITY JOURNAL; SEROPREVALENCE; UNITED STATES;

EID: 0033998786     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310332     Document Type: Article

References (19)

1. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, Miller, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-2235.
2. Alter M, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
3. Seeff LB. Natural history of hepatitis C. HEPATOLOGY 1997;26(Suppl 1):21S-28S.
4. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, et al. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N Engl J Med 1991;325:1325-1329.
5. Koretz RL, Brezina M, Polito AJ, Quan S, Wilber J, Dinello R, Gitnick G, et al. Non-A, non-B post-transfusion hepatitis: comparing C and non-C hepatitis. HEPATOLOGY 1993;17:361-365.
6. Alter MJ, Mares A, Hadler SC, Maynard JE. The effect of under-reporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 1987;125:133-139.
7. Meunch H. Catalytic Models in Epidemiology. Cambridge, MA: Harvard University Press, 1959.
8. Ades AE, Nokes DJ. Modeling age- and time-specific incidence from seroprevalence: toxoplasmosis. Am J Epidemiol 1993;137:1022-1034.
9. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III, Laboratory Data File [Public use data file and documentation]. Hyattsville, MD; National Center for Health Statistics, 1996.
10. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
11. Alter MJ. Epidemiology of hepatitis C. HEPATOLOGY 1997;26(Suppl):62S-65S.
12. Seeff LB, Miller RN, Rabkin CS, Bales ZB, Smoak BL, Johnson LD, Kaplan EL. 45-50 year follow-up of hepatitis C virus (HCV) infection among young military recruits (Abstract]. HEPATOLOGY 1998;28(Suppl): 361A.
13. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. HEPATOLOGY 1997;26(Suppl):15S-20S.
14. Di Besceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-974.
15. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Hepatol 1993;88:240-243.
16. Mast EE, Alter MJ. Hepatitis C. Sem Ped Infect Dis 1997;8:17-22.
17. McHutchison JG, Kuo G, Houghton M, Choo QL, Redeker AG. Hepatitis C virus antibodies in acute icteric and chronic non-A, non-B hepatitis. Gastroenterology 1991;101:1117-1119.
18. Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, Alberti A, Ruol A. Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 1991;114:277-281.
19. Dittmann S, Roggendorf M, Durkop J, Wiese M, Lorbeer B, Deinhardt E Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991;13:323-327.